Watabe, K.; Kan, M.; Ohno, I.; Uchida, S.; Sudo, T.; Yokozuka, K.; Abe, A.; Nakaya, Y.; Ogane, Y.; Kurosaki, H.;
et al. Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study. Cancers 2026, 18, 194.
https://doi.org/10.3390/cancers18020194
AMA Style
Watabe K, Kan M, Ohno I, Uchida S, Sudo T, Yokozuka K, Abe A, Nakaya Y, Ogane Y, Kurosaki H,
et al. Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study. Cancers. 2026; 18(2):194.
https://doi.org/10.3390/cancers18020194
Chicago/Turabian Style
Watabe, Kazuki, Motoyasu Kan, Izumi Ohno, Sodai Uchida, Taiga Sudo, Koki Yokozuka, Akinori Abe, Yoshiki Nakaya, Yoshiki Ogane, Hiroki Kurosaki,
and et al. 2026. "Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study" Cancers 18, no. 2: 194.
https://doi.org/10.3390/cancers18020194
APA Style
Watabe, K., Kan, M., Ohno, I., Uchida, S., Sudo, T., Yokozuka, K., Abe, A., Nakaya, Y., Ogane, Y., Kurosaki, H., Sakai, M., Sekine, Y., Takahashi, T., Ouchi, M., Ohyama, H., Sakai, N., Takano, S., Takayashiki, T., Ohtsuka, M.,
& Kato, J.
(2026). Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study. Cancers, 18(2), 194.
https://doi.org/10.3390/cancers18020194
